latest news stock values companies glp-1 obesity cardiometabolic Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers Betting on GLP-1 - by

US$ 28.78

★★★★★ 4.4 (22 reviews)

US$ 27.58

★★★★★ 4.7 (20 reviews)

US$ 20.23

★★★★★ 4.4 (29 reviews)

US$ 25.60

★★★★★ 4.5 (23 reviews)

US$ 21.17

★★★★★ 4.1 (8 reviews)

US$ 26.65

★★★★★ 4.3 (19 reviews)

US$ 25.74

★★★★★ 4.0 (29 reviews)

US$ 26.36

★★★★★ 4.6 (21 reviews)

US$ 24.47

★★★★★ 4.5 (8 reviews)

US$ 24.76

★★★★★ 5.0 (15 reviews)

US$ 24.37

★★★★★ 4.7 (12 reviews)

US$ 27.28

★★★★★ 4.0 (17 reviews)

US$ 26.96

★★★★★ 4.9 (30 reviews)

US$ 20.50

★★★★★ 4.9 (8 reviews)

US$ 20.13

★★★★★ 4.1 (8 reviews)

US$ 28.82

★★★★★ 4.7 (29 reviews)

US$ 21.91

★★★★★ 4.2 (14 reviews)

US$ 24.21

★★★★★ 4.4 (21 reviews)

US$ 25.15

★★★★★ 4.7 (22 reviews)

US$ 29.60

★★★★★ 4.0 (16 reviews)